Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 2
1956 1
1957 1
1961 1
1962 1
1964 1
1968 3
1969 1
1971 1
1972 1
1973 1
1974 1
1975 1
1976 4
1977 1
1978 2
1979 2
1980 4
1981 8
1982 6
1983 5
1984 6
1985 5
1986 6
1987 7
1988 4
1989 9
1990 10
1991 6
1992 11
1993 15
1994 21
1995 12
1996 13
1997 17
1998 12
1999 18
2000 15
2001 29
2002 15
2003 26
2004 25
2005 19
2006 25
2007 25
2008 24
2009 30
2010 36
2011 37
2012 20
2013 28
2014 41
2015 42
2016 36
2017 50
2018 58
2019 32
2020 53
2021 37
2022 52
2023 41
2024 26
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

954 results

Results by year

Filters applied: . Clear all
Page 1
Lichenoid drug eruption from ophthalmic latanoprost.
Tran JM, Falkenberry SM, Hughes SR. Tran JM, et al. Int J Dermatol. 2023 Sep;62(9):e493-e494. doi: 10.1111/ijd.16602. Epub 2023 Feb 2. Int J Dermatol. 2023. PMID: 36732607 No abstract available.
Lichenoid drug eruption induced by erenumab.
Musicante M, Goenaga-Vázquez Y, Klimas N. Musicante M, et al. JAAD Case Rep. 2022 Nov 24;32:26-28. doi: 10.1016/j.jdcr.2022.11.018. eCollection 2023 Feb. JAAD Case Rep. 2022. PMID: 36606202 Free PMC article. No abstract available.
Lichenoid Drug Eruption Induced by Teriflunomide.
Agharbi FZ, Aasfara J, Oqbani K, Slamti K, Chiheb S. Agharbi FZ, et al. Ann Indian Acad Neurol. 2023 May-Jun;26(3):275-277. doi: 10.4103/aian.aian_27_23. Epub 2023 Jun 15. Ann Indian Acad Neurol. 2023. PMID: 37538413 Free PMC article.
Lichenoid drug eruptions are a type of skin reaction that is caused by medication and mimics idiopathic lichen planus. Various medications have been known to cause lichenoid drug eruptions, such as antibiotics, anti-convulsants, anti-diab
Lichenoid drug eruptions are a type of skin reaction that is caused by medication and mimics idiopathic lichen planus.
Immune checkpoint inhibitor-related dermatologic adverse events.
Geisler AN, Phillips GS, Barrios DM, Wu J, Leung DYM, Moy AP, Kern JA, Lacouture ME. Geisler AN, et al. J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23. J Am Acad Dermatol. 2020. PMID: 32454097 Free PMC article. Review.
Cutaneous immune-related adverse events include a diverse group of inflammatory reactions, with maculopapular rash, pruritus, psoriasiform and lichenoid eruptions being the most prevalent subtypes. Cutaneous immune-related adverse events occur early, with maculopapu …
Cutaneous immune-related adverse events include a diverse group of inflammatory reactions, with maculopapular rash, pruritus, psoriasiform a …
Imatinib mesylate-induced lichenoid drug eruption.
Penn EH, Chung HJ, Keller M. Penn EH, et al. Cutis. 2017 Mar;99(3):189-192. Cutis. 2017. PMID: 28398413 Review.
Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor initially approved by the US Food and Drug Administration in 2001 for chronic myeloid leukemia (CML). Since then, the number of indicated uses for imatinib has substantially increased. ...Other less common manifes …
Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor initially approved by the US Food and Drug Administration in 2001 for chr …
Rifampicin-induced lichenoid drug eruption.
Bhanja DB, Sil A, Panigrahi A, Chakraborty S. Bhanja DB, et al. Postgrad Med J. 2020 Dec;96(1142):782-783. doi: 10.1136/postgradmedj-2019-137435. Epub 2020 Feb 3. Postgrad Med J. 2020. PMID: 32015190 No abstract available.
Lichenoid drug eruption on the lower lip caused by anti-PD-1 monoclonal antibody: a case report and literature review.
Kan S, Ren H, Gao Z, Dai E, Liu Y, Yang L, Cai Q. Kan S, et al. Immunotherapy. 2021 Dec;13(17):1373-1378. doi: 10.2217/imt-2021-0234. Epub 2021 Oct 11. Immunotherapy. 2021. PMID: 34632814 Review.
Here we report the first case, to our knowledge, of oral lichenoid drug reaction triggered by toripalimab. A 78-year-old man who was diagnosed with systemic metastatic prostate cancer presented with ulcers on the lower lip after the fifth cycle of toripalimab. We di …
Here we report the first case, to our knowledge, of oral lichenoid drug reaction triggered by toripalimab. A 78-year-old man w …
Lichenoid drug eruption.
Brauer J, Votava HJ, Meehan S, Soter NA. Brauer J, et al. Dermatol Online J. 2009 Aug 15;15(8):13. Dermatol Online J. 2009. PMID: 19891921 Free article.
There were lymphocytes extending to the dermo-epidermal junction with vacuolar changes. A diagnosis of lichenoid drug eruption secondary to a proton-pump inhibitor was made. To the best of our knowledge, only one other case of lichenoid drug
There were lymphocytes extending to the dermo-epidermal junction with vacuolar changes. A diagnosis of lichenoid drug erupt
954 results